Prevalence and disease burden of chronic kidney disease
JC Lv, LX Zhang - Renal fibrosis: mechanisms and therapies, 2019 - Springer
Chronic kidney disease (CKD) has been recognized as a leading public health problem
worldwide. The global estimated prevalence of CKD is 13.4%(11.7–15.1%), and patients …
worldwide. The global estimated prevalence of CKD is 13.4%(11.7–15.1%), and patients …
Chronic kidney disease
Chronic kidney disease is a general term for heterogeneous disorders affecting kidney
structure and function. The 2002 guidelines for definition and classification of this disease …
structure and function. The 2002 guidelines for definition and classification of this disease …
[HTML][HTML] The contribution of chronic kidney disease to the global burden of major noncommunicable diseases
Noncommunicable diseases (NCDs) are the most common causes of premature death and
morbidity and have a major impact on health-care costs, productivity, and growth …
morbidity and have a major impact on health-care costs, productivity, and growth …
Evolving importance of kidney disease: from subspecialty to global health burden
In the past decade, kidney disease diagnosed with objective measures of kidney damage
and function has been recognised as a major public health burden. The population …
and function has been recognised as a major public health burden. The population …
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis
Background Chronic kidney disease (CKD) is a frequent, under-recognized condition and a
risk factor for renal failure and cardiovascular disease. Increasing evidence connects non …
risk factor for renal failure and cardiovascular disease. Increasing evidence connects non …
Discovery and prioritization of variants and genes for kidney function in> 1.2 million individuals
Genes underneath signals from genome-wide association studies (GWAS) for kidney
function are promising targets for functional studies, but prioritizing variants and genes is …
function are promising targets for functional studies, but prioritizing variants and genes is …
[PDF][PDF] Extrahepatic complications of nonalcoholic fatty liver disease
MJ Armstrong, LA Adams, A Canbay, WK Syn - Hepatology, 2014 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, and is
strongly associated with the metabolic syndrome. In the last decade, it has become apparent …
strongly associated with the metabolic syndrome. In the last decade, it has become apparent …
Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials
X **e, Y Liu, V Perkovic, X Li, T Ninomiya… - American Journal of …, 2016 - Elsevier
Background There is much uncertainty regarding the relative effects of angiotensin-
converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in …
converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in …
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis
Background Recent studies examined the prognostic impact of nonalcoholic fatty liver
disease (NAFLD) on the risk of incident chronic kidney disease (CKD). However, the extent …
disease (NAFLD) on the risk of incident chronic kidney disease (CKD). However, the extent …
Biomarkers of renal function, which and when?
ME Wasung, LS Chawla, M Madero - Clinica chimica acta, 2015 - Elsevier
Purpose of the review Acute kidney injury (AKI) and chronic kidney disease (CKD) are
conditions that substantially increase morbidity and mortality. Although novel biomarkers are …
conditions that substantially increase morbidity and mortality. Although novel biomarkers are …